KPWS
ABBV icon

Kestra Private Wealth Services’s AbbVie ABBV Stock Holding History

Kestra Private Wealth Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5M Buy
180,625
+3,439
+2% +$740K 0.5% 30
2026
Q1 		$38.5M Buy
177,186
+5,266
+3% +$1.17M 0.48% 36
2025
Q4 		$39.3M Buy
171,920
+829
+0.5% +$189K 0.49% 33
2025
Q3 		$39.6M Buy
171,091
+7,387
+5% +$1.5M 0.52% 30
2025
Q2 		$30.4M Buy
163,704
+10,179
+7% +$1.89M 0.44% 39
2025
Q1 		$32.2M Buy
153,525
+5,423
+4% +$1.05M 0.54% 35
2024
Q4 		$26.3M Buy
148,102
+8,835
+6% +$1.62M 0.45% 38
2024
Q3 		$27.5M Buy
139,267
+861
+0.6% +$161K 0.5% 35
2024
Q2 		$23.7M Buy
138,406
+21,793
+19% +$3.61M 0.48% 38
2024
Q1 		$21.2M Buy
116,613
+307
+0.3% +$52.9K 0.48% 40
2023
Q4 		$18M Buy
116,306
+7,289
+7% +$1.06M 0.46% 42
2023
Q3 		$16.3M Buy
109,017
+9,011
+9% +$1.32M 0.51% 40
2023
Q2 		$13.5M Buy
100,006
+1,371
+1% +$201K 0.46% 45
2023
Q1 		$15.7M Buy
98,635
+8,021
+9% +$1.23M 0.63% 26
2022
Q4 		$14.6M Buy
90,614
+368
+0.4% +$56.4K 0.74% 20
2022
Q3 		$12.1M Buy
90,246
+2,026
+2% +$291K 0.7% 19
2022
Q2 		$13.5M Sell
88,220
-6,812
-7% -$1.04M 0.77% 15
2022
Q1 		$15.4M Buy
95,032
+4,194
+5% +$609K 0.76% 16
2021
Q4 		$12.3M Buy
90,838
+2,247
+3% +$265K 0.59% 25
2021
Q3 		$9.56M Buy
88,591
+24,508
+38% +$2.8M 0.53% 30
2021
Q2 		$7.22M Buy
64,083
+5,986
+10% +$674K 0.44% 40
2021
Q1 		$6.29M Buy
58,097
+2,180
+4% +$233K 0.44% 51
2020
Q4 		$5.89M Sell
55,917
-830
-1% -$79.8K 0.43% 49
2020
Q3 		$4.98M Buy
+56,747
New +$5.34M 0.43% 54

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kestra Private Wealth Services's ABBV Position: Q2 2026 in Review

Kestra Private Wealth Services increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $740K and bringing the position to 180,625 shares worth $45.5M. The position accounts for 0.5% of the portfolio, ranked #30.

Kestra Private Wealth Services first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kestra Private Wealth Services held 180,625 shares of AbbVie worth $45.5M as of Q2 2026.
  • Kestra Private Wealth Services bought 3,439 AbbVie shares in Q2 2026, an estimated $740K.
  • AbbVie made up 0.5% of Kestra Private Wealth Services's portfolio in Q2 2026, its #30 holding.
  • Kestra Private Wealth Services first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.